Global Subcutaneous Medicine Delivery Devices Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The subcutaneous medicine delivery device is a method, formula, technology and system that transports pharmaceutical compounds into the body at the subcutaneous interface as needed to safely achieve its expected therapeutic effect.
LPI (LP Information)' newest research report, the “Subcutaneous Medicine Delivery Devices Industry Forecast” looks at past sales and reviews total world Subcutaneous Medicine Delivery Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Subcutaneous Medicine Delivery Devices sales for 2023 through 2029. With Subcutaneous Medicine Delivery Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Medicine Delivery Devices industry.
This Insight Report provides a comprehensive analysis of the global Subcutaneous Medicine Delivery Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subcutaneous Medicine Delivery Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Subcutaneous Medicine Delivery Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Medicine Delivery Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Medicine Delivery Devices.
The global Subcutaneous Medicine Delivery Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Subcutaneous Medicine Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Subcutaneous Medicine Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Subcutaneous Medicine Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Subcutaneous Medicine Delivery Devices players cover Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer and Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Medicine Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Subcutaneous Medicine Delivery Devices market?
What factors are driving Subcutaneous Medicine Delivery Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Subcutaneous Medicine Delivery Devices market opportunities vary by end market size?
How does Subcutaneous Medicine Delivery Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The subcutaneous medicine delivery device is a method, formula, technology and system that transports pharmaceutical compounds into the body at the subcutaneous interface as needed to safely achieve its expected therapeutic effect.
LPI (LP Information)' newest research report, the “Subcutaneous Medicine Delivery Devices Industry Forecast” looks at past sales and reviews total world Subcutaneous Medicine Delivery Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Subcutaneous Medicine Delivery Devices sales for 2023 through 2029. With Subcutaneous Medicine Delivery Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Medicine Delivery Devices industry.
This Insight Report provides a comprehensive analysis of the global Subcutaneous Medicine Delivery Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subcutaneous Medicine Delivery Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Subcutaneous Medicine Delivery Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Medicine Delivery Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Medicine Delivery Devices.
The global Subcutaneous Medicine Delivery Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Subcutaneous Medicine Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Subcutaneous Medicine Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Subcutaneous Medicine Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Subcutaneous Medicine Delivery Devices players cover Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer and Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Medicine Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Implantable Subcutaneous Medicine Delivery Device
- Injection Type Subcutaneous Medicine Delivery Device
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- Eli Lily
- Galaxo
- HMD pharmaceuticals
- Merck
- Novartis
- Novo Nordisk
- Pfizer
- Sanofi
- Teva Pharmaceutical
- Zogenix
- BD
- Insulet Corporation
- Enable Injections
- West Pharmaceutical Services
- Ypsomed AG
- Elcam Medical
- Amgen
- Wilhelm Haselmeier
What is the 10-year outlook for the global Subcutaneous Medicine Delivery Devices market?
What factors are driving Subcutaneous Medicine Delivery Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Subcutaneous Medicine Delivery Devices market opportunities vary by end market size?
How does Subcutaneous Medicine Delivery Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Subcutaneous Medicine Delivery Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Subcutaneous Medicine Delivery Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Subcutaneous Medicine Delivery Devices by Country/Region, 2018, 2022 & 2029
2.2 Subcutaneous Medicine Delivery Devices Segment by Type
2.2.1 Implantable Subcutaneous Medicine Delivery Device
2.2.2 Injection Type Subcutaneous Medicine Delivery Device
2.3 Subcutaneous Medicine Delivery Devices Sales by Type
2.3.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Subcutaneous Medicine Delivery Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Subcutaneous Medicine Delivery Devices Sale Price by Type (2018-2023)
2.4 Subcutaneous Medicine Delivery Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Subcutaneous Medicine Delivery Devices Sales by Application
2.5.1 Global Subcutaneous Medicine Delivery Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Subcutaneous Medicine Delivery Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Subcutaneous Medicine Delivery Devices Sale Price by Application (2018-2023)
3 GLOBAL SUBCUTANEOUS MEDICINE DELIVERY DEVICES BY COMPANY
3.1 Global Subcutaneous Medicine Delivery Devices Breakdown Data by Company
3.1.1 Global Subcutaneous Medicine Delivery Devices Annual Sales by Company (2018-2023)
3.1.2 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Company (2018-2023)
3.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Subcutaneous Medicine Delivery Devices Revenue by Company (2018-2023)
3.2.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Company (2018-2023)
3.3 Global Subcutaneous Medicine Delivery Devices Sale Price by Company
3.4 Key Manufacturers Subcutaneous Medicine Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Subcutaneous Medicine Delivery Devices Product Location Distribution
3.4.2 Players Subcutaneous Medicine Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SUBCUTANEOUS MEDICINE DELIVERY DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Subcutaneous Medicine Delivery Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Subcutaneous Medicine Delivery Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Subcutaneous Medicine Delivery Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Subcutaneous Medicine Delivery Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Subcutaneous Medicine Delivery Devices Sales Growth
4.4 APAC Subcutaneous Medicine Delivery Devices Sales Growth
4.5 Europe Subcutaneous Medicine Delivery Devices Sales Growth
4.6 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Growth
5 AMERICAS
5.1 Americas Subcutaneous Medicine Delivery Devices Sales by Country
5.1.1 Americas Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023)
5.1.2 Americas Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023)
5.2 Americas Subcutaneous Medicine Delivery Devices Sales by Type
5.3 Americas Subcutaneous Medicine Delivery Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subcutaneous Medicine Delivery Devices Sales by Region
6.1.1 APAC Subcutaneous Medicine Delivery Devices Sales by Region (2018-2023)
6.1.2 APAC Subcutaneous Medicine Delivery Devices Revenue by Region (2018-2023)
6.2 APAC Subcutaneous Medicine Delivery Devices Sales by Type
6.3 APAC Subcutaneous Medicine Delivery Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Subcutaneous Medicine Delivery Devices by Country
7.1.1 Europe Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023)
7.1.2 Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023)
7.2 Europe Subcutaneous Medicine Delivery Devices Sales by Type
7.3 Europe Subcutaneous Medicine Delivery Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Subcutaneous Medicine Delivery Devices by Country
8.1.1 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Type
8.3 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subcutaneous Medicine Delivery Devices
10.3 Manufacturing Process Analysis of Subcutaneous Medicine Delivery Devices
10.4 Industry Chain Structure of Subcutaneous Medicine Delivery Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Subcutaneous Medicine Delivery Devices Distributors
11.3 Subcutaneous Medicine Delivery Devices Customer
12 WORLD FORECAST REVIEW FOR SUBCUTANEOUS MEDICINE DELIVERY DEVICES BY GEOGRAPHIC REGION
12.1 Global Subcutaneous Medicine Delivery Devices Market Size Forecast by Region
12.1.1 Global Subcutaneous Medicine Delivery Devices Forecast by Region (2024-2029)
12.1.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Subcutaneous Medicine Delivery Devices Forecast by Type
12.7 Global Subcutaneous Medicine Delivery Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Eli Lily
13.2.1 Eli Lily Company Information
13.2.2 Eli Lily Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.2.3 Eli Lily Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Eli Lily Main Business Overview
13.2.5 Eli Lily Latest Developments
13.3 Galaxo
13.3.1 Galaxo Company Information
13.3.2 Galaxo Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.3.3 Galaxo Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Galaxo Main Business Overview
13.3.5 Galaxo Latest Developments
13.4 HMD pharmaceuticals
13.4.1 HMD pharmaceuticals Company Information
13.4.2 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.4.3 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 HMD pharmaceuticals Main Business Overview
13.4.5 HMD pharmaceuticals Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.5.3 Merck Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.6.3 Novartis Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.7.3 Novo Nordisk Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.8.3 Pfizer Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.9.3 Sanofi Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Teva Pharmaceutical
13.10.1 Teva Pharmaceutical Company Information
13.10.2 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.10.3 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teva Pharmaceutical Main Business Overview
13.10.5 Teva Pharmaceutical Latest Developments
13.11 Zogenix
13.11.1 Zogenix Company Information
13.11.2 Zogenix Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.11.3 Zogenix Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zogenix Main Business Overview
13.11.5 Zogenix Latest Developments
13.12 BD
13.12.1 BD Company Information
13.12.2 BD Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.12.3 BD Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 BD Main Business Overview
13.12.5 BD Latest Developments
13.13 Insulet Corporation
13.13.1 Insulet Corporation Company Information
13.13.2 Insulet Corporation Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.13.3 Insulet Corporation Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Insulet Corporation Main Business Overview
13.13.5 Insulet Corporation Latest Developments
13.14 Enable Injections
13.14.1 Enable Injections Company Information
13.14.2 Enable Injections Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.14.3 Enable Injections Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Enable Injections Main Business Overview
13.14.5 Enable Injections Latest Developments
13.15 West Pharmaceutical Services
13.15.1 West Pharmaceutical Services Company Information
13.15.2 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.15.3 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 West Pharmaceutical Services Main Business Overview
13.15.5 West Pharmaceutical Services Latest Developments
13.16 Ypsomed AG
13.16.1 Ypsomed AG Company Information
13.16.2 Ypsomed AG Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.16.3 Ypsomed AG Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Ypsomed AG Main Business Overview
13.16.5 Ypsomed AG Latest Developments
13.17 Elcam Medical
13.17.1 Elcam Medical Company Information
13.17.2 Elcam Medical Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.17.3 Elcam Medical Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Elcam Medical Main Business Overview
13.17.5 Elcam Medical Latest Developments
13.18 Amgen
13.18.1 Amgen Company Information
13.18.2 Amgen Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.18.3 Amgen Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Amgen Main Business Overview
13.18.5 Amgen Latest Developments
13.19 Wilhelm Haselmeier
13.19.1 Wilhelm Haselmeier Company Information
13.19.2 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.19.3 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Wilhelm Haselmeier Main Business Overview
13.19.5 Wilhelm Haselmeier Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Subcutaneous Medicine Delivery Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Subcutaneous Medicine Delivery Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Subcutaneous Medicine Delivery Devices by Country/Region, 2018, 2022 & 2029
2.2 Subcutaneous Medicine Delivery Devices Segment by Type
2.2.1 Implantable Subcutaneous Medicine Delivery Device
2.2.2 Injection Type Subcutaneous Medicine Delivery Device
2.3 Subcutaneous Medicine Delivery Devices Sales by Type
2.3.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Subcutaneous Medicine Delivery Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Subcutaneous Medicine Delivery Devices Sale Price by Type (2018-2023)
2.4 Subcutaneous Medicine Delivery Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Subcutaneous Medicine Delivery Devices Sales by Application
2.5.1 Global Subcutaneous Medicine Delivery Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Subcutaneous Medicine Delivery Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Subcutaneous Medicine Delivery Devices Sale Price by Application (2018-2023)
3 GLOBAL SUBCUTANEOUS MEDICINE DELIVERY DEVICES BY COMPANY
3.1 Global Subcutaneous Medicine Delivery Devices Breakdown Data by Company
3.1.1 Global Subcutaneous Medicine Delivery Devices Annual Sales by Company (2018-2023)
3.1.2 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Company (2018-2023)
3.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Subcutaneous Medicine Delivery Devices Revenue by Company (2018-2023)
3.2.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Company (2018-2023)
3.3 Global Subcutaneous Medicine Delivery Devices Sale Price by Company
3.4 Key Manufacturers Subcutaneous Medicine Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Subcutaneous Medicine Delivery Devices Product Location Distribution
3.4.2 Players Subcutaneous Medicine Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SUBCUTANEOUS MEDICINE DELIVERY DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Subcutaneous Medicine Delivery Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Subcutaneous Medicine Delivery Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Subcutaneous Medicine Delivery Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Subcutaneous Medicine Delivery Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Subcutaneous Medicine Delivery Devices Sales Growth
4.4 APAC Subcutaneous Medicine Delivery Devices Sales Growth
4.5 Europe Subcutaneous Medicine Delivery Devices Sales Growth
4.6 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Growth
5 AMERICAS
5.1 Americas Subcutaneous Medicine Delivery Devices Sales by Country
5.1.1 Americas Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023)
5.1.2 Americas Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023)
5.2 Americas Subcutaneous Medicine Delivery Devices Sales by Type
5.3 Americas Subcutaneous Medicine Delivery Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subcutaneous Medicine Delivery Devices Sales by Region
6.1.1 APAC Subcutaneous Medicine Delivery Devices Sales by Region (2018-2023)
6.1.2 APAC Subcutaneous Medicine Delivery Devices Revenue by Region (2018-2023)
6.2 APAC Subcutaneous Medicine Delivery Devices Sales by Type
6.3 APAC Subcutaneous Medicine Delivery Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Subcutaneous Medicine Delivery Devices by Country
7.1.1 Europe Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023)
7.1.2 Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023)
7.2 Europe Subcutaneous Medicine Delivery Devices Sales by Type
7.3 Europe Subcutaneous Medicine Delivery Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Subcutaneous Medicine Delivery Devices by Country
8.1.1 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Type
8.3 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subcutaneous Medicine Delivery Devices
10.3 Manufacturing Process Analysis of Subcutaneous Medicine Delivery Devices
10.4 Industry Chain Structure of Subcutaneous Medicine Delivery Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Subcutaneous Medicine Delivery Devices Distributors
11.3 Subcutaneous Medicine Delivery Devices Customer
12 WORLD FORECAST REVIEW FOR SUBCUTANEOUS MEDICINE DELIVERY DEVICES BY GEOGRAPHIC REGION
12.1 Global Subcutaneous Medicine Delivery Devices Market Size Forecast by Region
12.1.1 Global Subcutaneous Medicine Delivery Devices Forecast by Region (2024-2029)
12.1.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Subcutaneous Medicine Delivery Devices Forecast by Type
12.7 Global Subcutaneous Medicine Delivery Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Eli Lily
13.2.1 Eli Lily Company Information
13.2.2 Eli Lily Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.2.3 Eli Lily Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Eli Lily Main Business Overview
13.2.5 Eli Lily Latest Developments
13.3 Galaxo
13.3.1 Galaxo Company Information
13.3.2 Galaxo Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.3.3 Galaxo Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Galaxo Main Business Overview
13.3.5 Galaxo Latest Developments
13.4 HMD pharmaceuticals
13.4.1 HMD pharmaceuticals Company Information
13.4.2 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.4.3 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 HMD pharmaceuticals Main Business Overview
13.4.5 HMD pharmaceuticals Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.5.3 Merck Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.6.3 Novartis Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.7.3 Novo Nordisk Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.8.3 Pfizer Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.9.3 Sanofi Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Teva Pharmaceutical
13.10.1 Teva Pharmaceutical Company Information
13.10.2 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.10.3 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teva Pharmaceutical Main Business Overview
13.10.5 Teva Pharmaceutical Latest Developments
13.11 Zogenix
13.11.1 Zogenix Company Information
13.11.2 Zogenix Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.11.3 Zogenix Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zogenix Main Business Overview
13.11.5 Zogenix Latest Developments
13.12 BD
13.12.1 BD Company Information
13.12.2 BD Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.12.3 BD Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 BD Main Business Overview
13.12.5 BD Latest Developments
13.13 Insulet Corporation
13.13.1 Insulet Corporation Company Information
13.13.2 Insulet Corporation Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.13.3 Insulet Corporation Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Insulet Corporation Main Business Overview
13.13.5 Insulet Corporation Latest Developments
13.14 Enable Injections
13.14.1 Enable Injections Company Information
13.14.2 Enable Injections Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.14.3 Enable Injections Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Enable Injections Main Business Overview
13.14.5 Enable Injections Latest Developments
13.15 West Pharmaceutical Services
13.15.1 West Pharmaceutical Services Company Information
13.15.2 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.15.3 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 West Pharmaceutical Services Main Business Overview
13.15.5 West Pharmaceutical Services Latest Developments
13.16 Ypsomed AG
13.16.1 Ypsomed AG Company Information
13.16.2 Ypsomed AG Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.16.3 Ypsomed AG Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Ypsomed AG Main Business Overview
13.16.5 Ypsomed AG Latest Developments
13.17 Elcam Medical
13.17.1 Elcam Medical Company Information
13.17.2 Elcam Medical Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.17.3 Elcam Medical Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Elcam Medical Main Business Overview
13.17.5 Elcam Medical Latest Developments
13.18 Amgen
13.18.1 Amgen Company Information
13.18.2 Amgen Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.18.3 Amgen Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Amgen Main Business Overview
13.18.5 Amgen Latest Developments
13.19 Wilhelm Haselmeier
13.19.1 Wilhelm Haselmeier Company Information
13.19.2 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
13.19.3 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Wilhelm Haselmeier Main Business Overview
13.19.5 Wilhelm Haselmeier Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Subcutaneous Medicine Delivery Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Subcutaneous Medicine Delivery Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Implantable Subcutaneous Medicine Delivery Device
Table 4. Major Players of Injection Type Subcutaneous Medicine Delivery Device
Table 5. Global Subcutaneous Medicine Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 6. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
Table 7. Global Subcutaneous Medicine Delivery Devices Revenue by Type (2018-2023) & ($ million)
Table 8. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2018-2023)
Table 9. Global Subcutaneous Medicine Delivery Devices Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Subcutaneous Medicine Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 11. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2018-2023)
Table 12. Global Subcutaneous Medicine Delivery Devices Revenue by Application (2018-2023)
Table 13. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2018-2023)
Table 14. Global Subcutaneous Medicine Delivery Devices Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Subcutaneous Medicine Delivery Devices Sales by Company (2018-2023) & (K Units)
Table 16. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Company (2018-2023)
Table 17. Global Subcutaneous Medicine Delivery Devices Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Company (2018-2023)
Table 19. Global Subcutaneous Medicine Delivery Devices Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Subcutaneous Medicine Delivery Devices Producing Area Distribution and Sales Area
Table 21. Players Subcutaneous Medicine Delivery Devices Products Offered
Table 22. Subcutaneous Medicine Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Subcutaneous Medicine Delivery Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Subcutaneous Medicine Delivery Devices Sales Market Share Geographic Region (2018-2023)
Table 27. Global Subcutaneous Medicine Delivery Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Subcutaneous Medicine Delivery Devices Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Country/Region (2018-2023)
Table 31. Global Subcutaneous Medicine Delivery Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 34. Americas Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2018-2023)
Table 35. Americas Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2018-2023)
Table 37. Americas Subcutaneous Medicine Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 38. Americas Subcutaneous Medicine Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 39. APAC Subcutaneous Medicine Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 40. APAC Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2018-2023)
Table 41. APAC Subcutaneous Medicine Delivery Devices Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2018-2023)
Table 43. APAC Subcutaneous Medicine Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 44. APAC Subcutaneous Medicine Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 45. Europe Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 46. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2018-2023)
Table 47. Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2018-2023)
Table 49. Europe Subcutaneous Medicine Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 50. Europe Subcutaneous Medicine Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Subcutaneous Medicine Delivery Devices
Table 58. Key Market Challenges & Risks of Subcutaneous Medicine Delivery Devices
Table 59. Key Industry Trends of Subcutaneous Medicine Delivery Devices
Table 60. Subcutaneous Medicine Delivery Devices Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Subcutaneous Medicine Delivery Devices Distributors List
Table 63. Subcutaneous Medicine Delivery Devices Customer List
Table 64. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Subcutaneous Medicine Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Subcutaneous Medicine Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Subcutaneous Medicine Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Subcutaneous Medicine Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Subcutaneous Medicine Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Subcutaneous Medicine Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Boehringer Ingelheim Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 80. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Eli Lily Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lily Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 85. Eli Lily Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Eli Lily Main Business
Table 87. Eli Lily Latest Developments
Table 88. Galaxo Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. Galaxo Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 90. Galaxo Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Galaxo Main Business
Table 92. Galaxo Latest Developments
Table 93. HMD pharmaceuticals Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 95. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. HMD pharmaceuticals Main Business
Table 97. HMD pharmaceuticals Latest Developments
Table 98. Merck Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 100. Merck Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Novartis Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 105. Novartis Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Novo Nordisk Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 109. Novo Nordisk Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 110. Novo Nordisk Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Novo Nordisk Main Business
Table 112. Novo Nordisk Latest Developments
Table 113. Pfizer Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 115. Pfizer Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. Sanofi Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanofi Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 120. Sanofi Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Sanofi Main Business
Table 122. Sanofi Latest Developments
Table 123. Teva Pharmaceutical Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 124. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 125. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Teva Pharmaceutical Main Business
Table 127. Teva Pharmaceutical Latest Developments
Table 128. Zogenix Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 129. Zogenix Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 130. Zogenix Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Zogenix Main Business
Table 132. Zogenix Latest Developments
Table 133. BD Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 134. BD Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 135. BD Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. BD Main Business
Table 137. BD Latest Developments
Table 138. Insulet Corporation Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 139. Insulet Corporation Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 140. Insulet Corporation Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. Insulet Corporation Main Business
Table 142. Insulet Corporation Latest Developments
Table 143. Enable Injections Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 144. Enable Injections Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 145. Enable Injections Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. Enable Injections Main Business
Table 147. Enable Injections Latest Developments
Table 148. West Pharmaceutical Services Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 149. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 150. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 151. West Pharmaceutical Services Main Business
Table 152. West Pharmaceutical Services Latest Developments
Table 153. Ypsomed AG Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 154. Ypsomed AG Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 155. Ypsomed AG Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 156. Ypsomed AG Main Business
Table 157. Ypsomed AG Latest Developments
Table 158. Elcam Medical Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 159. Elcam Medical Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 160. Elcam Medical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 161. Elcam Medical Main Business
Table 162. Elcam Medical Latest Developments
Table 163. Amgen Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 164. Amgen Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 165. Amgen Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 166. Amgen Main Business
Table 167. Amgen Latest Developments
Table 168. Wilhelm Haselmeier Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 169. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 170. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 171. Wilhelm Haselmeier Main Business
Table 172. Wilhelm Haselmeier Latest Developments
Table 1. Subcutaneous Medicine Delivery Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Subcutaneous Medicine Delivery Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Implantable Subcutaneous Medicine Delivery Device
Table 4. Major Players of Injection Type Subcutaneous Medicine Delivery Device
Table 5. Global Subcutaneous Medicine Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 6. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
Table 7. Global Subcutaneous Medicine Delivery Devices Revenue by Type (2018-2023) & ($ million)
Table 8. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2018-2023)
Table 9. Global Subcutaneous Medicine Delivery Devices Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Subcutaneous Medicine Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 11. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2018-2023)
Table 12. Global Subcutaneous Medicine Delivery Devices Revenue by Application (2018-2023)
Table 13. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2018-2023)
Table 14. Global Subcutaneous Medicine Delivery Devices Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Subcutaneous Medicine Delivery Devices Sales by Company (2018-2023) & (K Units)
Table 16. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Company (2018-2023)
Table 17. Global Subcutaneous Medicine Delivery Devices Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Company (2018-2023)
Table 19. Global Subcutaneous Medicine Delivery Devices Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Subcutaneous Medicine Delivery Devices Producing Area Distribution and Sales Area
Table 21. Players Subcutaneous Medicine Delivery Devices Products Offered
Table 22. Subcutaneous Medicine Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Subcutaneous Medicine Delivery Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Subcutaneous Medicine Delivery Devices Sales Market Share Geographic Region (2018-2023)
Table 27. Global Subcutaneous Medicine Delivery Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Subcutaneous Medicine Delivery Devices Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Country/Region (2018-2023)
Table 31. Global Subcutaneous Medicine Delivery Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 34. Americas Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2018-2023)
Table 35. Americas Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2018-2023)
Table 37. Americas Subcutaneous Medicine Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 38. Americas Subcutaneous Medicine Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 39. APAC Subcutaneous Medicine Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 40. APAC Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2018-2023)
Table 41. APAC Subcutaneous Medicine Delivery Devices Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2018-2023)
Table 43. APAC Subcutaneous Medicine Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 44. APAC Subcutaneous Medicine Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 45. Europe Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 46. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2018-2023)
Table 47. Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2018-2023)
Table 49. Europe Subcutaneous Medicine Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 50. Europe Subcutaneous Medicine Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Subcutaneous Medicine Delivery Devices
Table 58. Key Market Challenges & Risks of Subcutaneous Medicine Delivery Devices
Table 59. Key Industry Trends of Subcutaneous Medicine Delivery Devices
Table 60. Subcutaneous Medicine Delivery Devices Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Subcutaneous Medicine Delivery Devices Distributors List
Table 63. Subcutaneous Medicine Delivery Devices Customer List
Table 64. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Subcutaneous Medicine Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Subcutaneous Medicine Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Subcutaneous Medicine Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Subcutaneous Medicine Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Subcutaneous Medicine Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Subcutaneous Medicine Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Boehringer Ingelheim Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 80. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Eli Lily Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lily Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 85. Eli Lily Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Eli Lily Main Business
Table 87. Eli Lily Latest Developments
Table 88. Galaxo Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. Galaxo Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 90. Galaxo Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Galaxo Main Business
Table 92. Galaxo Latest Developments
Table 93. HMD pharmaceuticals Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 95. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. HMD pharmaceuticals Main Business
Table 97. HMD pharmaceuticals Latest Developments
Table 98. Merck Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 100. Merck Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Novartis Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 105. Novartis Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Novo Nordisk Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 109. Novo Nordisk Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 110. Novo Nordisk Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Novo Nordisk Main Business
Table 112. Novo Nordisk Latest Developments
Table 113. Pfizer Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 115. Pfizer Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. Sanofi Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanofi Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 120. Sanofi Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Sanofi Main Business
Table 122. Sanofi Latest Developments
Table 123. Teva Pharmaceutical Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 124. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 125. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Teva Pharmaceutical Main Business
Table 127. Teva Pharmaceutical Latest Developments
Table 128. Zogenix Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 129. Zogenix Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 130. Zogenix Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Zogenix Main Business
Table 132. Zogenix Latest Developments
Table 133. BD Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 134. BD Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 135. BD Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. BD Main Business
Table 137. BD Latest Developments
Table 138. Insulet Corporation Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 139. Insulet Corporation Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 140. Insulet Corporation Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. Insulet Corporation Main Business
Table 142. Insulet Corporation Latest Developments
Table 143. Enable Injections Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 144. Enable Injections Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 145. Enable Injections Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. Enable Injections Main Business
Table 147. Enable Injections Latest Developments
Table 148. West Pharmaceutical Services Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 149. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 150. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 151. West Pharmaceutical Services Main Business
Table 152. West Pharmaceutical Services Latest Developments
Table 153. Ypsomed AG Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 154. Ypsomed AG Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 155. Ypsomed AG Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 156. Ypsomed AG Main Business
Table 157. Ypsomed AG Latest Developments
Table 158. Elcam Medical Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 159. Elcam Medical Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 160. Elcam Medical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 161. Elcam Medical Main Business
Table 162. Elcam Medical Latest Developments
Table 163. Amgen Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 164. Amgen Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 165. Amgen Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 166. Amgen Main Business
Table 167. Amgen Latest Developments
Table 168. Wilhelm Haselmeier Basic Information, Subcutaneous Medicine Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 169. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product Portfolios and Specifications
Table 170. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 171. Wilhelm Haselmeier Main Business
Table 172. Wilhelm Haselmeier Latest Developments
LIST OF FIGURES
Figure 1. Picture of Subcutaneous Medicine Delivery Devices
Figure 2. Subcutaneous Medicine Delivery Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Subcutaneous Medicine Delivery Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Subcutaneous Medicine Delivery Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Subcutaneous Medicine Delivery Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Implantable Subcutaneous Medicine Delivery Device
Figure 10. Product Picture of Injection Type Subcutaneous Medicine Delivery Device
Figure 11. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type in 2022
Figure 12. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2018-2023)
Figure 13. Subcutaneous Medicine Delivery Devices Consumed in Hospitals
Figure 14. Global Subcutaneous Medicine Delivery Devices Market: Hospitals (2018-2023) & (K Units)
Figure 15. Subcutaneous Medicine Delivery Devices Consumed in Clinics
Figure 16. Global Subcutaneous Medicine Delivery Devices Market: Clinics (2018-2023) & (K Units)
Figure 17. Subcutaneous Medicine Delivery Devices Consumed in Others
Figure 18. Global Subcutaneous Medicine Delivery Devices Market: Others (2018-2023) & (K Units)
Figure 19. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2022)
Figure 20. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application in 2022
Figure 21. Subcutaneous Medicine Delivery Devices Sales Market by Company in 2022 (K Units)
Figure 22. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Company in 2022
Figure 23. Subcutaneous Medicine Delivery Devices Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Company in 2022
Figure 25. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Subcutaneous Medicine Delivery Devices Sales 2018-2023 (K Units)
Figure 28. Americas Subcutaneous Medicine Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 29. APAC Subcutaneous Medicine Delivery Devices Sales 2018-2023 (K Units)
Figure 30. APAC Subcutaneous Medicine Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 31. Europe Subcutaneous Medicine Delivery Devices Sales 2018-2023 (K Units)
Figure 32. Europe Subcutaneous Medicine Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 35. Americas Subcutaneous Medicine Delivery Devices Sales Market Share by Country in 2022
Figure 36. Americas Subcutaneous Medicine Delivery Devices Revenue Market Share by Country in 2022
Figure 37. Americas Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
Figure 38. Americas Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2018-2023)
Figure 39. United States Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Subcutaneous Medicine Delivery Devices Sales Market Share by Region in 2022
Figure 44. APAC Subcutaneous Medicine Delivery Devices Revenue Market Share by Regions in 2022
Figure 45. APAC Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
Figure 46. APAC Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2018-2023)
Figure 47. China Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Country in 2022
Figure 55. Europe Subcutaneous Medicine Delivery Devices Revenue Market Share by Country in 2022
Figure 56. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
Figure 57. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2018-2023)
Figure 58. Germany Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2018-2023)
Figure 67. Egypt Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Subcutaneous Medicine Delivery Devices in 2022
Figure 73. Manufacturing Process Analysis of Subcutaneous Medicine Delivery Devices
Figure 74. Industry Chain Structure of Subcutaneous Medicine Delivery Devices
Figure 75. Channels of Distribution
Figure 76. Global Subcutaneous Medicine Delivery Devices Sales Market Forecast by Region (2024-2029)
Figure 77. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Subcutaneous Medicine Delivery Devices Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Subcutaneous Medicine Delivery Devices Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Subcutaneous Medicine Delivery Devices
Figure 2. Subcutaneous Medicine Delivery Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Subcutaneous Medicine Delivery Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Subcutaneous Medicine Delivery Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Subcutaneous Medicine Delivery Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Implantable Subcutaneous Medicine Delivery Device
Figure 10. Product Picture of Injection Type Subcutaneous Medicine Delivery Device
Figure 11. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type in 2022
Figure 12. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2018-2023)
Figure 13. Subcutaneous Medicine Delivery Devices Consumed in Hospitals
Figure 14. Global Subcutaneous Medicine Delivery Devices Market: Hospitals (2018-2023) & (K Units)
Figure 15. Subcutaneous Medicine Delivery Devices Consumed in Clinics
Figure 16. Global Subcutaneous Medicine Delivery Devices Market: Clinics (2018-2023) & (K Units)
Figure 17. Subcutaneous Medicine Delivery Devices Consumed in Others
Figure 18. Global Subcutaneous Medicine Delivery Devices Market: Others (2018-2023) & (K Units)
Figure 19. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2022)
Figure 20. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application in 2022
Figure 21. Subcutaneous Medicine Delivery Devices Sales Market by Company in 2022 (K Units)
Figure 22. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Company in 2022
Figure 23. Subcutaneous Medicine Delivery Devices Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Company in 2022
Figure 25. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Subcutaneous Medicine Delivery Devices Sales 2018-2023 (K Units)
Figure 28. Americas Subcutaneous Medicine Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 29. APAC Subcutaneous Medicine Delivery Devices Sales 2018-2023 (K Units)
Figure 30. APAC Subcutaneous Medicine Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 31. Europe Subcutaneous Medicine Delivery Devices Sales 2018-2023 (K Units)
Figure 32. Europe Subcutaneous Medicine Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 35. Americas Subcutaneous Medicine Delivery Devices Sales Market Share by Country in 2022
Figure 36. Americas Subcutaneous Medicine Delivery Devices Revenue Market Share by Country in 2022
Figure 37. Americas Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
Figure 38. Americas Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2018-2023)
Figure 39. United States Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Subcutaneous Medicine Delivery Devices Sales Market Share by Region in 2022
Figure 44. APAC Subcutaneous Medicine Delivery Devices Revenue Market Share by Regions in 2022
Figure 45. APAC Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
Figure 46. APAC Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2018-2023)
Figure 47. China Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Country in 2022
Figure 55. Europe Subcutaneous Medicine Delivery Devices Revenue Market Share by Country in 2022
Figure 56. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
Figure 57. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2018-2023)
Figure 58. Germany Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2018-2023)
Figure 67. Egypt Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Subcutaneous Medicine Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Subcutaneous Medicine Delivery Devices in 2022
Figure 73. Manufacturing Process Analysis of Subcutaneous Medicine Delivery Devices
Figure 74. Industry Chain Structure of Subcutaneous Medicine Delivery Devices
Figure 75. Channels of Distribution
Figure 76. Global Subcutaneous Medicine Delivery Devices Sales Market Forecast by Region (2024-2029)
Figure 77. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Subcutaneous Medicine Delivery Devices Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Subcutaneous Medicine Delivery Devices Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Application (2024-2029)
